đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The use of Rituximab has been proposed to be useful and avoid the use of ra...
Status
Completed
Location
Oncology Research Unit
Start Date
2002-06
Trial ID
NCT01230008
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells ...
Status
Active Not Recruiting
Location
University of Arizona Cancer Center - North Campus /ID# 227463
Start Date
2023-02-08
Trial ID
NCT05578976
Treatments Being Tested
This study is a phase III, randomized, open-label, international, multicent...
Status
Recruiting
Location
Krankenhaus der Barmherzigen BrĂŒder Graz - Abteilung FĂŒr Innere Medizin I
Start Date
2024-06-07
Trial ID
NCT06284122
This is an open-label, multicentre Phase Ib study to evaluate the safety an...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-04-10
Trial ID
NCT06251180
Treatments Being Tested
270 untreated patients, age between 18 and 65 years , with diffuse large B-...
Status
Unknown
Location
Fourth Hospital of Hebei Medical University
Start Date
2016-11
Trial ID
NCT03022123
Treatments Being Tested
This is a prospective, observational, multicenter, cohort study with 400 ne...
Status
Recruiting
Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai
Start Date
2025-01-01
Trial ID
NCT06779435
Treatments Being Tested
B-cell non-Hodgkin's lymphoma (B-NHL) is the most common type of NHL. Altho...
Status
Unknown
Location
Shandong Provincial Hospital
Start Date
2021-04-15
Trial ID
NCT05097443
RATIONALE: Monoclonal antibodies such as rituximab and yttrium Y 90 ibritum...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2003-02-10
Trial ID
NCT00058422
The goal of the study is to identify a dose and schedule of CC-486 that can...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2015-04-29
Trial ID
NCT02343536
Treatments Being Tested
Tucidinostat (formerly known as chidamide) is an oral subtype-selective his...
Status
Completed
Location
Peking University Cancer Hospital
Start Date
2020-05-21
Trial ID
NCT04231448